Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,314 warrant series at 1,053 companies. 775 in the money, 58 expiring in the next 30 days, 36 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Common Stock Warrants (May 20, 2026 Underwritten Offering) | $0.7368 | $37.5M | 10-Q, Aug 7, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series A Common Stock Warrants (May 29, 2026 D&O Offering) | $0.7368 | $37.5M | 10-Q, Aug 7, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series B Common Stock Warrants (May 20, 2026 Underwritten Offering) | $0.7368 | $37.5M | 10-Q, Aug 7, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series B Common Stock Warrants (May 29, 2026 D&O Offering) | $0.7368 | $37.5M | 10-Q, Aug 7, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| ATHOA listed options (A$1.40, expiring February 26, 2027) — free-attaching options from the February 2025 Placement | $1.86 | $37.4M | 20-F, Aug 28, 2026Dilution tabAs of Oct 30, 2026 | ||||||||
| Avenue lender warrant (November 4, 2025) | $0.9189 | $36.8M | 10-K, Mar 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Pre-funded warrants (January 2023 and August 2023 offerings, aggregate) | $0.9189 | $36.8M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Debenture Warrants (issued with Initial Debenture Units, January 2024) | $3.00 | $36.5M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Lyle Berman warrants (debt-financing related, per beneficial-ownership footnote) | $1.74 | $36.5M | 10-K, Mar 31, 2026Dilution tabAs of Oct 30, 2026 | ||||||||
| May 2024 IPO underwriter (Roth representative) warrants | $1.74 | $36.5M | 10-K, Mar 31, 2026Dilution tabAs of Oct 30, 2026 | ||||||||
| Pre-funded warrants (October 2025 public offering) | $2.14 | $36.5M | 10-Q, Aug 10, 2026Dilution tabAs of Sep 8, 2026 | ||||||||
| Series A common stock warrants (October 2025 public offering) | $2.14 | $36.5M | 10-Q, Aug 10, 2026Dilution tabAs of Sep 8, 2026 | ||||||||
| Series B common stock warrants (October 2025 public offering) | $2.14 | $36.5M | 10-Q, Aug 10, 2026Dilution tabAs of Sep 8, 2026 | ||||||||
| Backstop Warrants (Corvina Holdings) | $0.8459 | $36.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Other outstanding common stock warrants (issuer aggregate line, incl. Legacy Grove Warrants) | $0.8459 | $36.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Private Placement Warrants (Sponsor) | $0.8459 | $36.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Public Warrants (VGAC II SPAC public warrants) | $0.8459 | $36.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Former executive warrant (Edmundo Gonzalez) ($2.50) | $1.35 | $36.3M | 8-K EX-1.1, Dec 11, 2023Dilution tabAs of Nov 13, 2026 | ||||||||
| Private placement common warrants ($1.00) — December 22, 2025 offering | $1.35 | $36.3M | 10-K, Mar 25, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Private placement common warrants ($1.00) — October/November 2025 offering | $1.35 | $36.3M | 10-K, Mar 25, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Underwriter's (Representative's) Warrants — April 2023 public offering ($5.00) | $1.35 | $36.3M | S-1, Dec 23, 2024Dilution tabAs of Nov 13, 2026 | ||||||||
| Warrants at $20.00 exercise price (78,125 shares) | $1.35 | $36.3M | S-1, Dec 23, 2024Dilution tabAs of Nov 13, 2026 | ||||||||
| 2024 Uplisting Offering Representatives' Warrants | $0.8175 | $36.3M | 10-K, Apr 13, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Incentive Warrants (Juvenescence) | $1.36 | $36.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Incentive Warrants (other holders) | $1.36 | $36.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Pre-Funded Warrants (March 2026 PIPE) | $1.36 | $36.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Redeemable Warrants (March 2026 PIPE, $5.00) | $1.36 | $36.3M | S-3, May 22, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Replacement Incentive Warrants (Juvenescence) | $1.36 | $36.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Common warrants issued in connection with February 2025 private placement (2025 Common Warrants) | $1.72 | $36.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Pre-funded warrants issued in connection with February 2025 private placement (2025 Pre-Funded Warrants) | $1.72 | $36.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Pre-funded warrants issued in connection with September 2023 private placement (2023 Pre-Funded Warrants) | $1.72 | $36.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| 2025 Warrants (registered direct, SPA dated March 31, 2025) | $1.55 | $36.1M | F-1/A, Apr 24, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| 2026 Warrants (Share Subscription Agreement dated March 6, 2026) | $1.55 | $36.1M | 20-F, Apr 17, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| August 2026 Private Placement Warrants (SPA dated August 28, 2026) | $1.55 | $36.1M | 6-K, Aug 31, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| FA Warrants (financial advisor, March 2024 registered direct offering) | $1.55 | $36.1M | 20-F, Apr 17, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Investor Warrants (March 2024 registered direct offering) | $1.55 | $36.1M | 20-F, Apr 17, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Market Warrants – HPC III Kaizen LP ($10.00, expiring May 1, 2029) | $1.12 | $35.8M | 10-Q, Nov 4, 2026Dilution tabAs of Nov 5, 2026 | ||||||||
| Market Warrants – HPS and affiliates ($10.00, expiring May 1, 2029) | $1.12 | $35.8M | 10-Q, Nov 4, 2026Dilution tabAs of Nov 5, 2026 | ||||||||
| Penny Warrants – HPC III Kaizen LP ($0.01, expiring May 1, 2034) | $1.12 | $35.8M | 10-Q, Nov 4, 2026Dilution tabAs of Nov 5, 2026 | ||||||||
| Penny Warrants – HPS and affiliates ($0.01, expiring May 1, 2034) | $1.12 | $35.8M | 10-Q, Nov 4, 2026Dilution tabAs of Nov 5, 2026 | ||||||||
| June 2025 common warrants ($2.50, expiring December 20, 2026) | $0.4880 | $35.5M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| October 2025 common warrants ($2.50, expiring October 8, 2028) | $0.4880 | $35.5M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| November 2026 Pre-Funded Warrants | $0.6500 | $35.2M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Pre-Funded Warrants (May 2023, Series H/I exercise, and August 2025 issuances — aggregate) | $0.6500 | $35.2M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series J Warrants (Amended, $0.7674) | $0.6500 | $35.2M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series J Warrants (Unamended, $1.3827) | $0.6500 | $35.2M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series K Warrants (Amended, $0.7674) | $0.6500 | $35.2M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series L Warrants | $0.6500 | $35.2M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Converted SOC 2022 Warrants (Form of 2022 SOC Warrant Certificate), exercise price $32.61, expiring January 2027 | $9.46 | $35.0M | 10-K, Mar 20, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Convertible Note Warrants - Modified (March-May 2026 issuances, repriced May 26, 2026) | $1.95 | $35.0M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 |
RPIDRapid Micro Biosystems, Inc.$0.7368Last price
Series A Common Stock Warrants (May 20, 2026 Underwritten Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$37.5M
RPIDRapid Micro Biosystems, Inc.$0.7368Last price
Series A Common Stock Warrants (May 29, 2026 D&O Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$37.5M
RPIDRapid Micro Biosystems, Inc.$0.7368Last price
Series B Common Stock Warrants (May 20, 2026 Underwritten Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$37.5M
RPIDRapid Micro Biosystems, Inc.$0.7368Last price
Series B Common Stock Warrants (May 29, 2026 D&O Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$37.5M
ATHEAlterity Therapeutics Limited American Depositary Shares$1.86Last price
ATHOA listed options (A$1.40, expiring February 26, 2027) — free-attaching options from the February 2025 Placement
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$37.4M
MYOMyomo, Inc.$0.9189Last price
Avenue lender warrant (November 4, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.8M
MYOMyomo, Inc.$0.9189Last price
Pre-funded warrants (January 2023 and August 2023 offerings, aggregate)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.8M
MLCIMount Logan Capital Inc.$3.00Last price
Debenture Warrants (issued with Initial Debenture Units, January 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.5M
SOWGSow Good Inc.$1.74Last price
Lyle Berman warrants (debt-financing related, per beneficial-ownership footnote)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.5M
SOWGSow Good Inc.$1.74Last price
May 2024 IPO underwriter (Roth representative) warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.5M
VERUVeru Inc.$2.14Last price
Pre-funded warrants (October 2025 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.5M
VERUVeru Inc.$2.14Last price
Series A common stock warrants (October 2025 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.5M
VERUVeru Inc.$2.14Last price
Series B common stock warrants (October 2025 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.5M
GROVGrove Collaborative Holdings, Inc.$0.8459Last price
Backstop Warrants (Corvina Holdings)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
GROVGrove Collaborative Holdings, Inc.$0.8459Last price
Other outstanding common stock warrants (issuer aggregate line, incl. Legacy Grove Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
GROVGrove Collaborative Holdings, Inc.$0.8459Last price
Private Placement Warrants (Sponsor)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
GROVGrove Collaborative Holdings, Inc.$0.8459Last price
Public Warrants (VGAC II SPAC public warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
MRAIMarpai, Inc.$1.35Last price
Former executive warrant (Edmundo Gonzalez) ($2.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
MRAIMarpai, Inc.$1.35Last price
Private placement common warrants ($1.00) — December 22, 2025 offering
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
MRAIMarpai, Inc.$1.35Last price
Private placement common warrants ($1.00) — October/November 2025 offering
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
MRAIMarpai, Inc.$1.35Last price
Underwriter's (Representative's) Warrants — April 2023 public offering ($5.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
MRAIMarpai, Inc.$1.35Last price
Warrants at $20.00 exercise price (78,125 shares)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
WETHWetouch Technology Inc. Common Stock$0.8175Last price
2024 Uplisting Offering Representatives' Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
SERSerina Therapeutics, Inc.$1.36Last price
Incentive Warrants (Juvenescence)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
SERSerina Therapeutics, Inc.$1.36Last price
Incentive Warrants (other holders)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
SERSerina Therapeutics, Inc.$1.36Last price
Pre-Funded Warrants (March 2026 PIPE)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
SERSerina Therapeutics, Inc.$1.36Last price
Redeemable Warrants (March 2026 PIPE, $5.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
SERSerina Therapeutics, Inc.$1.36Last price
Replacement Incentive Warrants (Juvenescence)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.3M
GRCEGrace Therapeutics, Inc.$1.72Last price
Common warrants issued in connection with February 2025 private placement (2025 Common Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.2M
GRCEGrace Therapeutics, Inc.$1.72Last price
Pre-funded warrants issued in connection with February 2025 private placement (2025 Pre-Funded Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.2M
GRCEGrace Therapeutics, Inc.$1.72Last price
Pre-funded warrants issued in connection with September 2023 private placement (2023 Pre-Funded Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.2M
NAASNaaS Technology Inc. American Depositary Shares$1.55Last price
2025 Warrants (registered direct, SPA dated March 31, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.1M
NAASNaaS Technology Inc. American Depositary Shares$1.55Last price
2026 Warrants (Share Subscription Agreement dated March 6, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.1M
NAASNaaS Technology Inc. American Depositary Shares$1.55Last price
August 2026 Private Placement Warrants (SPA dated August 28, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.1M
NAASNaaS Technology Inc. American Depositary Shares$1.55Last price
FA Warrants (financial advisor, March 2024 registered direct offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.1M
NAASNaaS Technology Inc. American Depositary Shares$1.55Last price
Investor Warrants (March 2024 registered direct offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$36.1M
STKSThe ONE Group Hospitality, Inc.$1.12Last price
Market Warrants – HPC III Kaizen LP ($10.00, expiring May 1, 2029)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$35.8M
STKSThe ONE Group Hospitality, Inc.$1.12Last price
Market Warrants – HPS and affiliates ($10.00, expiring May 1, 2029)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$35.8M
STKSThe ONE Group Hospitality, Inc.$1.12Last price
Penny Warrants – HPC III Kaizen LP ($0.01, expiring May 1, 2034)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$35.8M
STKSThe ONE Group Hospitality, Inc.$1.12Last price
Penny Warrants – HPS and affiliates ($0.01, expiring May 1, 2034)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$35.8M
BMEABiomea Fusion, Inc.$0.4880Last price
June 2025 common warrants ($2.50, expiring December 20, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$35.5M
BMEABiomea Fusion, Inc.$0.4880Last price
October 2025 common warrants ($2.50, expiring October 8, 2028)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$35.5M
NSPRInspireMD, Inc.$0.6500Last price
November 2026 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$35.2M
NSPRInspireMD, Inc.$0.6500Last price
Pre-Funded Warrants (May 2023, Series H/I exercise, and August 2025 issuances — aggregate)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$35.2M
NSPRInspireMD, Inc.$0.6500Last price
Series J Warrants (Amended, $0.7674)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$35.2M
NSPRInspireMD, Inc.$0.6500Last price
Series J Warrants (Unamended, $1.3827)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$35.2M
NSPRInspireMD, Inc.$0.6500Last price
Series K Warrants (Amended, $0.7674)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$35.2M
NSPRInspireMD, Inc.$0.6500Last price
Series L Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$35.2M
STRRStar Equity Holdings, Inc.$9.46Last price
Converted SOC 2022 Warrants (Form of 2022 SOC Warrant Certificate), exercise price $32.61, expiring January 2027
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$35.0M
SCWO374Water Inc.$1.95Last price
Convertible Note Warrants - Modified (March-May 2026 issuances, repriced May 26, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$35.0M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,064 dilution snapshots. 4,861 of 5,314 series state an exercise price and 3,370 an expiry date. 148 record when exercise begins; that count grows as companies are re-extracted. 623 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.